Karin Jirström
301 – 310 of 344
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Vascular endothelial growth factor receptor 2 is a significant negative prognostic biomarker in triple-negative breast cancer: results from a controlled randomised trial of premenopausal breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
CRIM1 is localized to the podocyte filtration slit diaphragm of the adult human kidney
(
- Contribution to journal › Article
-
Mark
SOX11 but not SOX4 is a prognostic marker for improved recurrence free survival in epithelial ovarian cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Molecular evolution of specific human antibody against MUC1 mucin results in improved recognition of the antigen on tumour cells
(
- Contribution to journal › Article
-
Mark
The Prognostic Significance of Tryptophanyl-tRNA Synthetase in Colorectal Cancer
(
- Contribution to journal › Article
-
Mark
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
2009) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 22. p.1564-1574(
- Contribution to journal › Article
-
Mark
Cyclin A Is a Proliferative Marker with Good Prognostic Value in Node-Negative Breast Cancer.
2009) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18. p.2501-2506(
- Contribution to journal › Article
-
Mark
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.
(
- Contribution to journal › Article
-
Mark
Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer.
(
- Contribution to journal › Article